Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat

QR Code

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat

Major problem for diabetic patients represents damage of blood vessels and the oxidative stress of the brain cells due to increased concentration of free radicals and poor nutrition of brain cells. Gliclazide has antioxidative properties and poor blood brain barrier (BBB) penetration. Bile acids are...

Full description

Bibliographic Details
Main Authors:	Lalic-Popovic, M., Vasovic, V., Milijasevic, B., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.
Format:	Journal Article
Published:	Hindawi Publishing Corporation 2013
Online Access:	http://hdl.handle.net/20.500.11937/15627

Similar Items

Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)

THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)

The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine
by: Lalic-Popovic, M., et al.
Published: (2016)

Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008)

Pharmacokinetic and Drug Absorption Profiles of the Anti-Hyperglycaemic Agent Gliclazide in Oral Tissue-Targeted Microcapsules in Rats
by: Jovic, Jelena, et al.
Published: (2020)

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)

Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)

Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes
by: Lalic-Popovic, M., et al.
Published: (2015)

Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology
by: Fakhoury, M., et al.
Published: (2015)

Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
by: Al-Salami, Hani, et al.
Published: (2008)

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)

Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)

Transdermal permeation mechanism of sodium deoxycholate aided nano-transfersomes by Differentail Sacnning Calorimetry (DSC)
by: Mahmood, Syed, et al.
Published: (2015)

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients
by: Lalic, M., et al.
Published: (2009)

Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring
by: Maksimovic, V., et al.
Published: (2017)

Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring
by: Golocorbin-Kon, S., et al.
Published: (2018)

A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes
by: Mathavan, Sangeetha, et al.
Published: (2015)

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)

Phytocannabinoids, neuroprotection and the blood-brain barrier
by: Stone, Nicole
Published: (2021)

Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids
by: Brook, E., et al.
Published: (2019)

Probiotics applications in autoimmune diseases
by: Al-Salami, Hani, et al.
Published: (2012)

Alginate-deoxycholic Acid Interaction and Its Impact on Pancreatic ?-Cells and Insulin Secretion and Potential Treatment of Type 1 Diabetes
by: Mooranian, Armin, et al.
Published: (2016)

Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations
by: Elmorsy, Ekramy, et al.
Published: (2017)

Blood-brain barrier derangement after electrical brain stimulation
by: Watanabe, Yumiko, et al.
Published: (2017)

Safety of anodal transcranial direct current stimulation with respect to blood-brain barrier permeability in the rat
by: Nik-Mohd-Afizan, NAR, et al.
Published: (2017)

Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet
by: Mamo, John, et al.
Published: (2018)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

Nipah virus neurotropism: insights into blood-brain barrier disruption
by: Al Obaidi, Mazen M Jamil, et al.
Published: (2024)

Blood-Brain Barrier on-a-chip model for the study of drug permeability into the brain
by: Whitehouse, Chloe Ann
Published: (2022)

Establishment of horse blood-brain barrier model for the study of drug delivery to the brain
by: Gupta, Gaurav
Published: (2025)

Changes Of The Blood-Brain Barrier Permeability, Ultrastructure, And Protein And Gene Expressions In A Rat Model Of Cerebral Hypoperfusion
by: Sekaran, Hema
Published: (2019)

Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)

Understanding the mechanisms underlying the disruption of the blood–brain barrier in parasitic infections
by: Jamil Al‐Obaidi, Mazen M., et al.
Published: (2024)

Alterations in the endothelial cells of the blood-brain barrier in cerebral malaria
by: Mohd Nasir, Mohd Hamzah, et al.
Published: (2012)

Endocannabinoids modulate human blood-brain barrier permeabilityin vitro
by: Hind, William H., et al.
Published: (2015)

Modern methods for delivery of drugs across the blood-brain barrier
by: Chen, Yan, et al.
Published: (2012)